Related Experiment Videos
Bupropion for amphetamine withdrawal syndrome
T Chan-Ob1, N Kuntawongse, V Boonyanaruthee
1Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Thailand.
Summary
This case report shows that bupropion effectively treated amphetamine withdrawal symptoms, including cravings. The medication helped alleviate dysphoria, fatigue, and somnolence within days.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Amphetamine abuse and dependence are significant public health concerns.
- Amphetamine withdrawal syndrome presents with various distressing symptoms.
- Limited pharmacological options exist for managing amphetamine withdrawal.
Observation:
- A case of prolonged amphetamine abuse presented with withdrawal symptoms.
- Symptoms included dysphoric mood, fatigue, somnolence, and psychomotor retardation.
- The patient had abstained from amphetamine use for three days prior to presentation.
Findings:
- Treatment with slow-release bupropion (150 mg/day) was initiated.
- Bupropion administration led to the gradual disappearance of withdrawal symptoms within 2-3 days.
- The patient experienced a complete absence of amphetamine craving during treatment.
Implications:
- Bupropion may be a viable therapeutic option for managing amphetamine withdrawal.
- This finding suggests a potential role for bupropion in treating amphetamine dependence.
- Further clinical research is warranted to confirm bupropion's efficacy and safety in larger cohorts.